Skip to main content
Premium Trial:

Request an Annual Quote

Ono Pharma Licenses Genedata's Software for Proteomics and Metabolomics Research

Premium

Genedata said last week that Ono Pharmaceutical has licensed its Genedata Expressionist for Mass Spectrometry solution and that the Japanese firm would use the tool in its proteomics and metabolomics research efforts.

Ono develops drugs for cancer and cardiovascular diseases. Its research requires "accurate mass profiling analysis as well as powerful [multiple reaction monitoring] capabilities for effective quantitative analysis," a spokesperson for Ono's Tsukuba Research Institute said in a statement.

Genedata's platform, the representative said, is able to integrate data from a variety of instruments and is able to identify clinically relevant biomarkers.

Genedata is not disclosing the financial details of the licensing agreement.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.